mAbバイオシミラー市場インサイト2019:世界及び中国の市場分析・予測

Prof Researchが発行した調査報告書(PROF9J09717)
◆英語タイトル:mAb Biosimilar Market Insights 2019, Global and Chinese Analysis and Forecast to 2024
◆商品コード:PROF9J09717
◆発行会社(リサーチ会社):Prof Research
◆発行日:2019年6月
◆ページ数:144
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル、中国
◆産業分野:医療・製薬・バイオ
◆販売価格オプション(消費税別)
Single User(1名閲覧用)USD3,000 ⇒換算¥312,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD3,800 ⇒換算¥395,200見積依頼/購入/質問フォーム
Global Site License(複数事業所内共有可)USD5,000 ⇒換算¥520,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はProf Research社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。Prof Research社の概要及び新刊レポートはこちらでご確認いただけます。

世界及び中国におけるmAbバイオシミラー市場について調査・分析したレポートで、mAbバイオシミラーの世界市場動向、市場規模、主要企業情報などが含まれています。mAbバイオシミラーの種類別・用途別に分けて分析し、地域別には、アメリカ、ヨーロッパ、日本、中国などに区分してまとめてあります。
・mAbバイオシミラー産業の概要
・mAbバイオシミラーの製造技術分析
・主要企業分析:企業概要、製品情報、連絡先など
・世界及び中国のmAbバイオシミラー市場 2014年-2019年
・世界及び中国のmAbバイオシミラー市場現状
・企業別分析:Baxter, GSK, Merck, Novartis, Pfizer, Roche Holding, Sanofi, Mitsubishi Tanabe Pharma, Hospira, Alvartis Pharma, Allergan, Amega Biotech, Biogen, LG Lifesciences, Samsung Biologics など
・地域別分析:アメリカ、ヨーロッパ、日本、中国など
・種類別分析、用途別分析
・世界及び中国のmAbバイオシミラー市場予測 2019年-2024年
・mAbバイオシミラーの産業チェーン分析
・世界及び中国のマクロ経済動向と影響
・世界及び中国のmAbバイオシミラー市場動向・課題・機会
・新規プロジェクトへの提言・結論
【レポートの概要】

mAb Biosimilar Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global mAb Biosimilar industry with a focus on the Chinese market. The report provides key statistics on the market status of the mAb Biosimilar manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.Overall, the report provides an in-depth insight of 2014-2024 global and Chinese mAb Biosimilar market covering all important parameters.

The key ponits of the report:
1.The report provides a basic overview of the industry including its definition, applications and manufacturing technology.
2.The report explores the international and Chinese major industry players in detail. In this part, the report presents the company profile, product specifications, capacity, production value, and 2014-2019 market shares for each company.
3.Through the statistical analysis, the report depicts the global and Chinese total market of mAb Biosimilar industry including capacity, production, production value, cost/profit, supply/demand and Chinese import/export.
4.The total market is further divided by company, by country, and by application/type for the competitive landscape analysis.
5.The report then estimates 2019-2024 market development trends of mAb Biosimilar industry. Analysis of upstream raw materials, downstream demand, and current market dynamics is also carried out.
6.The report makes some important proposals for a new project of mAb Biosimilar Industry before evaluating its feasibility.

There are 3 key segments covered in this report: competitor segment, product type segment, end use/application segment.

For competitor segment, the report includes global key players of mAb Biosimilar as well as some small players. At least 15 companies are included:
* Baxter
* GSK
* Merck
* Novartis
* Pfizer
* Roche Holding
For complete companies list, please ask for sample pages.

The information for each competitor includes:
* Company Profile
* Main Business Information
* SWOT Analysis
* Sales, Revenue, Price and Gross Margin
* Market Share

For product type segment, this report listed main product type of mAb Biosimilar market in gloabal and china.
* Product Type I
* Product Type II
* Product Type III

For end use/application segment, this report focuses on the status and outlook for key applications. End users sre also listed.
* Application I
* Application II
* Application III

Reasons to Purchase this Report:

* Estimates 2019-2024 mAb Biosimilar market development trends with the recent trends and SWOT analysis
* Market dynamics scenario, along with growth opportunities of the market in the years to come
* Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
* Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
* Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
* Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
* Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
* 1-year analyst support, along with the data support in excel format.

Any special requirements about this report, please let us know and we can provide custom report.

【レポートの目次】

Chapter One Introduction of mAb Biosimilar Industry
1.1 Brief Introduction of mAb Biosimilar
1.2 Development of mAb Biosimilar Industry
1.3 Status of mAb Biosimilar Industry

Chapter Two Manufacturing Technology of mAb Biosimilar
2.1 Development of mAb Biosimilar Manufacturing Technology
2.2 Analysis of mAb Biosimilar Manufacturing Technology
2.3 Trends of mAb Biosimilar Manufacturing Technology

Chapter Three Analysis of Global Key Manufacturers
3.1 Baxter
3.1.1 Company Profile
3.1.2 Product Information
3.1.3 2014-2019 Production Information
3.1.4 Contact Information
3.2 GSK
3.2.1 Company Profile
3.2.2 Product Information
3.2.3 2014-2019 Production Information
3.2.4 Contact Information
3.3 Merck
3.2.1 Company Profile
3.3.2 Product Information
3.3.3 2014-2019 Production Information
3.3.4 Contact Information
3.4 Novartis
3.4.1 Company Profile
3.4.2 Product Information
3.4.3 2014-2019 Production Information
3.4.4 Contact Information
3.5 Pfizer
3.5.1 Company Profile
3.5.2 Product Information
3.5.3 2014-2019 Production Information
3.5.4 Contact Information
3.6 Roche Holding
3.6.1 Company Profile
3.6.2 Product Information
3.5.3 2014-2019 Production Information
3.6.4 Contact Information
3.7 Sanofi
3.7.1 Company Profile
3.7.2 Product Information
3.7.3 2014-2019 Production Information
3.7.4 Contact Information
3.8 Company H
3.8.1 Company Profile
3.8.2 Product Information
3.8.3 2014-2019 Production Information
3.8.4 Contact Information
……
……

Chapter Four 2014-2019 Global and Chinese Market of mAb Biosimilar
4.1 2014-2019 Global Capacity, Production and Production Value of mAb Biosimilar Industry
4.2 2014-2019 Global Cost and Profit of mAb Biosimilar Industry
4.3 Market Comparison of Global and Chinese mAb Biosimilar Industry
4.4 2014-2019 Global and Chinese Supply and Consumption of mAb Biosimilar
4.5 2014-2019 Chinese Import and Export of mAb Biosimilar

Chapter Five Market Status of mAb Biosimilar Industry
5.1 Market Competition of mAb Biosimilar Industry by Company
5.2 Market Competition of mAb Biosimilar Industry by Country (USA, EU, Japan, Chinese etc.)
5.3 Market Analysis of mAb Biosimilar Consumption by Application/Type

Chapter Six 2019-2024 Market Forecast of Global and Chinese mAb Biosimilar Industry
6.1 2019-2024 Global and Chinese Capacity, Production, and Production Value of mAb Biosimilar
6.2 2019-2024 mAb Biosimilar Industry Cost and Profit Estimation
6.3 2019-2024 Global and Chinese Market Share of mAb Biosimilar
6.4 2019-2024 Global and Chinese Supply and Consumption of mAb Biosimilar
6.5 2019-2024 Chinese Import and Export of mAb Biosimilar

Chapter Seven Analysis of mAb Biosimilar Industry Chain
7.1 Industry Chain Structure
7.2 Upstream Raw Materials
7.3 Downstream Industry

Chapter Eight Global and Chinese Economic Impact on mAb Biosimilar Industry
8.1 Global and Chinese Macroeconomic Environment Analysis
8.1.1 Global Macroeconomic Analysis
8.1.2 Chinese Macroeconomic Analysis
8.2 Global and Chinese Macroeconomic Environment Development Trend
8.2.1 Global Macroeconomic Outlook
8.2.2 Chinese Macroeconomic Outlook
8.3 Effects to mAb Biosimilar Industry

Chapter Nine Market Dynamics of mAb Biosimilar Industry
9.1 mAb Biosimilar Industry News
9.2 mAb Biosimilar Industry Development Challenges
9.3 mAb Biosimilar Industry Development Opportunities

Chapter Ten Proposals for New Project
10.1 Market Entry Strategies
10.2 Countermeasures of Economic Impact
10.3 Marketing Channels
10.4 Feasibility Studies of New Project Investment

Chapter Eleven Research Conclusions of Global and Chinese mAb Biosimilar Industry

Tables and Figures
Figure mAb Biosimilar Product Picture
Table Development of mAb Biosimilar Manufacturing Technology
Figure Manufacturing Process of mAb Biosimilar
Table Trends of mAb Biosimilar Manufacturing Technology
Figure mAb Biosimilar Product and Specifications
Table 2014-2019 mAb Biosimilar Product Capacity, Production, and Production Value etc. List
Figure 2014-2019 mAb Biosimilar Capacity Production and Growth Rate
Figure 2014-2019 mAb Biosimilar Production Global Market Share
Figure mAb Biosimilar Product and Specifications
Table 2014-2019 mAb Biosimilar Product Capacity, Production, and Production Value etc. List
Figure 2014-2019 mAb Biosimilar Capacity Production and Growth Rate
Figure 2014-2019 mAb Biosimilar Production Global Market Share
Figure mAb Biosimilar Product and Specifications
Table 2014-2019 mAb Biosimilar Product Capacity Production Price Cost Production Value List
Figure 2014-2019 mAb Biosimilar Capacity Production and Growth Rate
Figure 2014-2019 mAb Biosimilar Production Global Market Share
Figure mAb Biosimilar Product and Specifications
Table 2014-2019 mAb Biosimilar Product Capacity, Production, and Production Value etc. List
Figure 2014-2019 mAb Biosimilar Capacity Production and Growth Rate
Figure 2014-2019 mAb Biosimilar Production Global Market Share
Figure mAb Biosimilar Product and Specifications
Table 2014-2019 mAb Biosimilar Product Capacity Production Price Cost Production Value List
Figure 2014-2019 mAb Biosimilar Capacity Production and Growth Rate
Figure 2014-2019 mAb Biosimilar Production Global Market Share
Figure mAb Biosimilar Product and Specifications
Table 2014-2019 mAb Biosimilar Product Capacity, Production, and Production Value etc. List
Figure 2014-2019 mAb Biosimilar Capacity Production and Growth Rate
Figure 2014-2019 mAb Biosimilar Production Global Market Share
Figure mAb Biosimilar Product and Specifications
Table 2014-2019 mAb Biosimilar Product Capacity, Production, and Production Value etc. List
Figure 2014-2019 mAb Biosimilar Capacity Production and Growth Rate
Figure 2014-2019 mAb Biosimilar Production Global Market Share
Figure mAb Biosimilar Product and Specifications
Table 2014-2019 mAb Biosimilar Product Capacity, Production, and Production Value etc. List
Figure 2014-2019 mAb Biosimilar Capacity Production and Growth Rate
Figure 2014-2019 mAb Biosimilar Production Global Market Share
……
……
Table 2014-2019 Global mAb Biosimilar Capacity List
Table 2014-2019 Global mAb Biosimilar Key Manufacturers Capacity Share List
Figure 2014-2019 Global mAb Biosimilar Manufacturers Capacity Share
Table 2014-2019 Global mAb Biosimilar Key Manufacturers Production List
Table 2014-2019 Global mAb Biosimilar Key Manufacturers Production Share List
Figure 2014-2019 Global mAb Biosimilar Manufacturers Production Share
Figure 2014-2019 Global mAb Biosimilar Capacity Production and Growth Rate
Table 2014-2019 Global mAb Biosimilar Key Manufacturers Production Value List
Figure 2014-2019 Global mAb Biosimilar Production Value and Growth Rate
Table 2014-2019 Global mAb Biosimilar Key Manufacturers Production Value Share List
Figure 2014-2019 Global mAb Biosimilar Manufacturers Production Value Share
Table 2014-2019 Global mAb Biosimilar Capacity Production Cost Profit and Gross Margin List
Figure 2014-2019 Chinese Share of Global mAb Biosimilar Production
Table 2014-2019 Global Supply and Consumption of mAb Biosimilar
Table 2014-2019 Import and Export of mAb Biosimilar
Figure 2018 Global mAb Biosimilar Key Manufacturers Capacity Market Share
Figure 2018 Global mAb Biosimilar Key Manufacturers Production Market Share
Figure 2018 Global mAb Biosimilar Key Manufacturers Production Value Market Share
Table 2014-2019 Global mAb Biosimilar Key Countries Capacity List
Figure 2014-2019 Global mAb Biosimilar Key Countries Capacity
Table 2014-2019 Global mAb Biosimilar Key Countries Capacity Share List
Figure 2014-2019 Global mAb Biosimilar Key Countries Capacity Share
Table 2014-2019 Global mAb Biosimilar Key Countries Production List
Figure 2014-2019 Global mAb Biosimilar Key Countries Production
Table 2014-2019 Global mAb Biosimilar Key Countries Production Share List
Figure 2014-2019 Global mAb Biosimilar Key Countries Production Share
Table 2014-2019 Global mAb Biosimilar Key Countries Consumption Volume List
Figure 2014-2019 Global mAb Biosimilar Key Countries Consumption Volume
Table 2014-2019 Global mAb Biosimilar Key Countries Consumption Volume Share List
Figure 2014-2019 Global mAb Biosimilar Key Countries Consumption Volume Share
Figure 78 2014-2019 Global mAb Biosimilar Consumption Volume Market by Application
Table 89 2014-2019 Global mAb Biosimilar Consumption Volume Market Share List by Application
Figure 79 2014-2019 Global mAb Biosimilar Consumption Volume Market Share by Application
Table 90 2014-2019 Chinese mAb Biosimilar Consumption Volume Market List by Application
Figure 80 2014-2019 Chinese mAb Biosimilar Consumption Volume Market by Application
Figure 2019-2024 Global mAb Biosimilar Capacity Production and Growth Rate
Figure 2019-2024 Global mAb Biosimilar Production Value and Growth Rate
Table 2019-2024 Global mAb Biosimilar Capacity Production Cost Profit and Gross Margin List
Figure 2019-2024 Chinese Share of Global mAb Biosimilar Production
Table 2019-2024 Global Supply and Consumption of mAb Biosimilar
Table 2019-2024 Import and Export of mAb Biosimilar
Figure Industry Chain Structure of mAb Biosimilar Industry
Figure Production Cost Analysis of mAb Biosimilar
Figure Downstream Analysis of mAb Biosimilar
Table Growth of World output, 2014 – 2019, Annual Percentage Change
Figure Unemployment Rates in Selected Developed Countries, January 2014 – March 2018
Figure Nominal Effective Exchange Rate: Japan and Selected Emerging Economies, September 2014-March 2018
Figure 2014-2019 Chinese GDP and Growth Rates
Figure 2014-2019 Chinese CPI Changes
Figure 2014-2019 Chinese PMI Changes
Figure 2014-2019 Chinese Financial Revenue and Growth Rate
Figure 2014-2019 Chinese Total Fixed Asset Investment and Growth Rate
Figure 2019-2024 Chinese GDP and Growth Rates
Figure 2019-2024 Chinese CPI Changes
Table Economic Effects to mAb Biosimilar Industry
Table mAb Biosimilar Industry Development Challenges
Table mAb Biosimilar Industry Development Opportunities
Figure Map of Chinese 33 Provinces and Administrative Regions
Table Selected Cities According to Industrial Orientation
Figure Chinese IPR Strategy
Table Brief Summary of Suggestions
Table New mAb Biosimilars Project Feasibility Study



【掲載企業】

Baxter, GSK, Merck, Novartis, Pfizer, Roche Holding, Sanofi, Mitsubishi Tanabe Pharma, Hospira, Alvartis Pharma, Allergan, Amega Biotech, Biogen, LG Lifesciences, Samsung Biologics

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ mAbバイオシミラー市場インサイト2019:世界及び中国の市場分析・予測(mAb Biosimilar Market Insights 2019, Global and Chinese Analysis and Forecast to 2024)]についてメールでお問い合わせはこちらでお願いします。